Consenso

← vista completa

Publicado el 1 de enero de 2009 | http://doi.org/10.5867/medwave.2010.01.4335

Revisión de la literatura para la actualización de los requisitos, requerimientos técnicos e indicaciones del linfonodo centinela axilar en cáncer de mama

Literature review to update the requisites, technical requirements, and indications of axillary sentinel lymph node in breast cancer

Ricardo Schwartz, Marcela Amar, Juan Carlos Acevedo, Mauricio Camus, Ana María Donoso, Marcela Fritis, Álvaro Ibarra, Kuen Lee, Brenda Luarte, Pablo Matamala, Sonia Neubauer, Jorge Pierart, Constanza Rojas, Eufrosina Traipe, Marcia Valenzuela

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Ricardo Schwartz

Marcela Amar

Juan Carlos Acevedo

Mauricio Camus

Ana María Donoso

Marcela Fritis

Álvaro Ibarra

Kuen Lee

Brenda Luarte

Pablo Matamala

Sonia Neubauer

Jorge Pierart

Constanza Rojas

Eufrosina Traipe

Marcia Valenzuela

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Schwartz R, Amar M, Acevedo JC, Camus M, Donoso AM, Fritis Met al. Literature review to update the requisites, technical requirements, and indications of axillary sentinel lymph node in breast cancer. Medwave 2010;10(1):e4335 doi: 10.5867/medwave.2010.01.4335

Envío 11/08/2009

Aceptación 26/08/2009

Publicación 01/01/2010

Indice

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Keywords

linfonodo centinela axilar, cáncer de mama

Provenance and peer review

con revisión por pares externa

Referencias

  1. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005 Apr;35(2):116-28. | CrossRef | PubMed
  2. Abe H, Schmidt RA, Sennett CA, Shimauchi A, Newstead GM. US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it. Radiographics. 2007 Oct;27 Suppl 1:S91-9. | CrossRef | PubMed
  3. Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003 Jan;77(1):9-14. | CrossRef | PubMed
  4. Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006 May;186(5):1342-8. | CrossRef | PubMed
  5. Anan K, Mitsuyama S, Kuga H, Saimura M, Tanabe Y, Suehara N, et al. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection. Surgery. 2006 May; 139(5): 624-9. | CrossRef | PubMed
  6. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008 May;95(5):547-54. | CrossRef | PubMed
  7. Avisar E, Molina MA, Scarlata M, Moffat FL. Internal mammary sentinel node biopsy for breast cancer. Am J Surg. 2008 Oct;196(4):490-4. Epub 2008 Aug 23. | CrossRef | PubMed
  8. Baitchev G, Gortchev G, Todorova A. Intraoperative sentinel lymph node examination by imprint cytology during breast surgery. Curr Med Res Opin. 2002;18(4):185-7. | CrossRef | PubMed
  9. Barros AC, Barros MA, Andrade FE, Mori LJ, Costa PA, Sheng PY, et al. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma. Ann Surg Oncol. 2007 Apr;14(4):1472-7. Epub 2007 Jan 17. | CrossRef | PubMed
  10. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008 Sep;191(3):646-52. | CrossRef | PubMed
  11. Behm EC, Buckingham JM. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do. ANZ J Surg. 2008 Mar;78(3):151-7. | CrossRef | PubMed
  12. Benson JR, della Rovere GQ; Axilla Management Consensus Group. Management of the axilla in women with breast cancer. Lancet Oncol. 2007 Apr;8(4):331-48. | CrossRef | PubMed
  13. Bergkvist L. Resolving the controversies surrounding lymphatic mapping in breast cancer. Future Oncol. 2008 Oct;4(5):681-8. | CrossRef | PubMed
  14. Bernstein V, Hayes M. Provincial Guidelines For Lymphatic Mapping And Sentinel Node Biopsy For Breast Cancer. BC Surgical Oncology Network. 2003
  15. Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006 Oct;203(4):475-80. Epub 2006 Aug 23. | CrossRef | PubMed
  16. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2154-9. | CrossRef | PubMed
  17. Carmon M, Olsha O, Rivkin L, Spira RM, Golomb E. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J. 2006 May-Jun;12(3):199-201. | CrossRef | PubMed
  18. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007 Dec;14(12):3378-84. Epub 2007 Sep 26. | CrossRef | PubMed
  19. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol. 2001 Oct;8(9):688-92. | CrossRef | PubMed
  20. Cipolla C, Vieni S, Fricano S, Cabibi D, Graceffa G, Costa R, et al. The accuracy of sentinel lymph node biopsy in the treatment of multicentric invasive breast cancer using a subareolar injection of tracer. World J Surg. 2008 Nov;32(11):2483-7. | CrossRef | PubMed
  21. Cserni G. Surgical pathological staging of breast cancer by sentinel lymph node biopsy with special emphasis on the histological work-up of axillary sentinel lymph nodes. Breast Cancer. 2004;11(3):242-9; discussion 264-6. | CrossRef | PubMed
  22. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2004 Jul;57(7):695-701. | CrossRef | PubMed
  23. Cserni G, Bianchi S, Boecker W, Decker T, Lacerda M, Rank F, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005 Jan 15;103(2):358-67. | CrossRef | PubMed
  24. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol. 1999 Sep;6(6):553-61. | CrossRef | PubMed
  25. Cox CE, Salud CJ, Cantor A, Bass SS, Peltz ES, Ebert MD, et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg. 2001 Dec;193(6):593-600. | CrossRef | PubMed
  26. Cox CE, Cox JM, White LB, Stowell NG, Clark JD, Allred N, et al. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol. 2006 Apr;13(4):483-90. Epub 2006 Mar 7. | CrossRef | PubMed
  27. Cox CE, Furman BT, Kiluk JV, Jara J, Koeppel W, Meade T, et al. Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg. 2008 Jul;207(1):57-61. | CrossRef | PubMed
  28. Cox CE, Kiluk JV, Riker AI, Cox JM, Allred N, Ramos DC, et al. Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg. 2008 Feb;206(2):261-8. Epub 2007 Dec 11. | CrossRef | PubMed
  29. Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Ann Shaw J, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol. 2002 Nov;15(11):1140-7. | CrossRef | PubMed
  30. Dabbs DJ, Johnson R. The optimal number of sentinel lymph nodes for focused pathologic examination. Breast J. 2004 May-Jun;10(3):186-9. | CrossRef | PubMed
  31. Duchesne N, Jaffey J, Florack P, Duchesne S. Redefining ultrasound appearance criteria of positive axillary lymph nodes. Can Assoc Radiol J. 2005 Dec;56(5):289-96. | PubMed
  32. Ferrari A, Dionigi P, Rovera F, Boni L, Limonta G, Garancini S, et al. Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery. World J Surg Oncol. 2006 Nov 20;4:79. | CrossRef | PubMed
  33. Fortunato L, Amini M, Costarelli L, Piro FR, Farina M, Vitelli CE. A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer. J Surg Oncol. 2007 Nov 1;96(6):470-3. | CrossRef | PubMed
  34. Fortunato L, Santoni M, Drago S, Gucciardo G, Farina M, Cesarini C, et al. Sentinel lymph node biopsy in women with pT1a or "microinvasive" breast cancer. Breast. 2008 Aug;17(4):395-400. Epub 2008 May 12. | CrossRef | PubMed
  35. Filippakis GM, Zografos G. Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol. 2007 Jan 29;5:10. | CrossRef | PubMed
  36. Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008 Apr;206(4):616-21. Epub 2008 Feb 21. | CrossRef | PubMed
  37. Fraile M, Gimenez J. Criterios de evaluación y estándares de calidad. Consenso sobre la biopsia selectiva del ganglio centinela en el Cancer de mama. 2007. | Link
  38. Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C, Gatti G, et al. Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist. 2007 May;12(5):512-5. | CrossRef | PubMed
  39. Graf RM, Canan LW Jr, Romano GG, Tolazzi AR, Cruz GA. Re: implications of transaxillary breast augmentation: lifetime probability for the development of breast cancer and sentinel node mapping interference. Aesthetic Plast Surg. 2007 Jul-Aug;31(4):322-4. | CrossRef | PubMed
  40. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg. 2004 Aug;188(2):122-5. | CrossRef | PubMed
  41. Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg. 2005 Jan;241(1):48-54. | PubMed
  42. Hino M, Sano M, Sato N, Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today. 2008;38(7):585-91. Epub 2008 Jul 9. | CrossRef | PubMed
  43. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg. 2005 Dec;92(12):1494-7. | CrossRef | PubMed
  44. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sacchini V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003 Mar;138(3):309-13. | CrossRef | PubMed
  45. Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, et al. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer. 2006 Nov 15;107(10):2328-36. | CrossRef | PubMed
  46. Kaleya RN, Heckman JT, Most M, Zager JS. Lymphatic mapping and sentinel node biopsy: a surgical perspective. Semin Nucl Med. 2005 Apr;35(2):129-34. | CrossRef | PubMed
  47. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008 May 1;26(13):2093-8. | CrossRef | PubMed
  48. Kavallaris A, Camara O, Runnebaum IB. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine. J Cancer Res Clin Oncol. 2008 Jun;134(6):667-72. Epub 2007 Nov 20. | CrossRef | PubMed
  49. Kidd SA, Keto JL, Tran H, Fitzgerald TL. First three sentinel lymph nodes accurately stage the axilla in breast cancer. Am Surg. 2009 Mar;75(3):253-6. | PubMed
  50. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007 Oct;8(10):881-8. | CrossRef | PubMed
  51. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006 Mar;13(3):310-20. Epub 2006 Feb 10. | CrossRef | PubMed
  52. Lelievre L, Houvenaeghel G, Buttarelli M, Brenot-Rossi I, Huiart L, Tallet A, et al. Value of the sentinel lymph node procedure in patients with large size breast cancer. Ann Surg Oncol. 2007 Feb;14(2):621-6. Epub 2006 Nov 12. | CrossRef | PubMed
  53. Liberman L, Cody HS 3rd. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol. 2001 Oct;177(4):887-91. | PubMed
  54. López R, Feu J. Radiología. 2007.
  55. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005 Oct 20;23(30):7703-20. Epub 2005 Sep 12. | CrossRef | PubMed
  56. McCarthy CM, Pusic AL, Disa JJ, Cordeiro PG, Cody HS 3rd, Mehrara B. Breast cancer in the previously augmented breast. Plast Reconstr Surg. 2007 Jan;119(1):49-58. | CrossRef | PubMed
  57. MacNeill F. NEW START: the UK SLNB training programme –a progress report. Ann R Coll Surg Engl 89: 60-61.
  58. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006 May 3;98(9):599-609. | CrossRef | PubMed
  59. Mansfield L, Sosa I, Dionello R, Subramanian A, Devalia H, Mokbel K. Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons. Int Semin Surg Oncol. 2007 Feb 14;4:4. | CrossRef | PubMed
  60. Moonka R, Hunter JA, Cray WK Jr, Duncan M, Wechter DG. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy. Am J Surg. 2002 May;183(5):558-61. | CrossRef | PubMed
  61. Motomura K, Nagumo S, Komoike Y, Koyama H, Inaji H. Intraoperative imprint cytology for the diagnosis of sentinel node metastases in breast cancer. Breast Cancer. 2007;14(4):350-3. | CrossRef | PubMed
  62. Munhoz AM, Aldrighi C, Buschpiegel C, Ono C, Montag E, Fells K, et al. The feasibility of sentinel lymph node detection in patients with previous transaxillary implant breast augmentation: preliminary results. Aesthetic Plast Surg. 2005 May-Jun;29(3):163-8. | CrossRef | PubMed
  63. Newman LA. Sentinel lymph node biopsy for breast cancer: will variations in technique influence long-term outcome? Ann Surg Oncol. 2005 Sep;12(9):686-8. Epub 2005 Aug 4. | CrossRef | PubMed
  64. O'Connell AM, O'Doherty A, Malone DE. Can ultrasound evaluate axillary lymph node status in patients with breast cancer? Can Assoc Radiol J. 2008 Feb;59(1):19-21. | PubMed
  65. Popli MB, Sahoo M, Mehrotra N, Choudhury M, Kumar A, Pathania OP, et al. Preoperative ultrasound-guided fine-needle aspiration cytology for axillary staging in breast carcinoma. Australas Radiol. 2006 Apr;50(2):122-6. | CrossRef | PubMed
  66. Prado A, Andrades P, Leniz P. Implications of transaxillary breast augmentation: lifetime probability of breast cancer development and sentinel node mapping interference. Aesthetic Plast Surg. 2007 Jul-Aug;31(4):317-9. | CrossRef | PubMed
  67. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg. 1999 Oct;86(10):1346-8. | CrossRef | PubMed
  68. Renshaw AA, Gould EW. Concentrated smear technique for examining sentinel lymph nodes of the breast at the time of frozen section. Am J Clin Pathol. 2004 Dec;122(6):944-6. | CrossRef | PubMed
  69. Rivers A, Hansen N. Axillary management after sentinel lymph node biopsy in breast cancer patients. Surg Clin North Am. 2007 Apr;87(2):365-77, ix. | CrossRef | PubMed
  70. Rodriguez Fernandez J, Martella S, Trifirò G, Caliskan M, Chifu C, Brenelli F, et al. Sentinel node biopsy in patients with previous breast aesthetic surgery. Ann Surg Oncol. 2009 Apr;16(4):989-92. Epub 2009 Feb 11. | CrossRef | PubMed
  71. Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol. 2007 Aug 20;25(24):3664-9. Epub 2007 May 7. | CrossRef | PubMed
  72. Rutgers EJ. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol. 2008 Feb 10;26(5):698-702. | CrossRef | PubMed
  73. Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 2003 Mar;185(3):202-10. | CrossRef | PubMed
  74. Sanidas EE, Daskalakis M, Sbyrakis N, Tsiftsis DD. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol. 2005 May;31(4):357-63. | CrossRef | PubMed
  75. Sapino A, Cassoni P, Zanon E, Fraire F, Croce S, Coluccia C, et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer. 2003 Mar 10;88(5):702-6. | CrossRef | PubMed
  76. Schüle J, Frisell J, Ingvar C, Bergkvist L. Sentinel node biopsy for breast cancer larger than 3 cm in diameter. Br J Surg. 2007 Aug;94(8):948-51. | CrossRef | PubMed
  77. Shin JH, Choi HY, Moon BI, Sung SH. In vitro sonographic evaluation of sentinel lymph nodes for detecting metastasis in breast cancer: comparison with histopathologic results. J Ultrasound Med. 2004 Jul;23(7):923-8. | PubMed
  78. Somasundaram SK, Chicken DW, Keshtgar MR. Detection of the sentinel lymph node in breast cancer. Br Med Bull. 2007;84:117-31. Epub 2008 Jan 3. | CrossRef | PubMed
  79. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002 Apr;9(3):235-42. | CrossRef | PubMed
  80. Tan JC, McCready DR, Easson AM, Leong WL. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol. 2007 Feb;14(2):638-45. Epub 2006 Nov 14. | CrossRef | PubMed
  81. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2001 Jul;54(7):550-2. | CrossRef | PubMed
  82. Treseler P. Pathologic examination of the sentinel lymph node: what is the best method? Breast J. 2006 Sep-Oct;12(5 Suppl 2):S143-51. | CrossRef | PubMed
  83. Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ. Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol. 2007 May;14(5):1662-9. Epub 2007 Feb 7. | CrossRef | PubMed
  84. van Esser S, Hobbelink MG, Peeters PH, Buskens E, van der Ploeg IM, Mali WP, et al. The efficacy of 'radio guided occult lesion localization' (ROLL) versus 'wire-guided localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized clinical trial - ROLL study. BMC Surg. 2008 May 21;8:9. | CrossRef | PubMed
  85. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003 Dec;10(10):1140-51. | CrossRef | PubMed
  86. van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006 Apr;13(4):475-9. Epub 2006 Feb 17. | CrossRef | PubMed
  87. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005 Feb;241(2):319-25. | CrossRef | PubMed
  88. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer. 2000 Mar 1;88(5):1099-107. | CrossRef | PubMed
  89. Weaver DL. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology. 2005 Jun;46(6):702-6. | CrossRef | PubMed
  90. Weaver DL, Krag DN, Manna EA, Ashikaga T, Waters BL, Harlow SP, et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study. Cancer. 2006 Aug 15;107(4):661-7. | CrossRef | PubMed
  91. Woznick A, Franco M, Bendick P, Benitez PR. Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg. 2006 Mar;191(3):330-3. | CrossRef | PubMed
  92. Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002 Mar;26(3):377-82. | CrossRef | PubMed
  93. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008 Jul;196(1):81-7. Epub 2008 Apr 23. | CrossRef | PubMed
  94. Zervos EE, Saha S, Hoshaw-Woodard S, Wheatley GH, Burak WE Jr. Localizing the sentinel node outside of the specialty center: success of a lymphatic mapping course in disseminating new technology. Ann Surg Oncol. 2001 Jan-Feb;8(1):7-12. | CrossRef | PubMed